Document Classification

Section Type: RESULTS

Text: In the LGG group, compared with the placebo group, we found a significantly reduced risk for gastrointestinal infections (relative risk [RR] : 0. 40 [95 % confidence interval (CI) : 0. 25-0. 70] ; number needed to treat : 15 [95 % CI : 9-34)], respiratory tract infections (RR : 0. 38 [95 % CI : 0. 18-0. 85] ; number needed to treat : 30 [95 % CI : 16-159]), vomiting episodes (RR : 0. 5 [95 % CI : 0. 3-0. 9]), diarrheal episodes (RR : 0. 24 [95 % CI : 0. 10-0. 50]), episodes of gastrointestinal infections that lasted > 2 days (RR : 0. 40 [95 % CI : 0. 25-0. 70]), and episodes of respiratory tract infections that lasted > 3 days (RR : 0. 4 [95 % CI : 0. 2-0. 9]).